Sign up USA
Proactive Investors - Run By Investors For Investors

M Pharmaceutical Inc to seek partners to distribute diabetic pain products

The firm purchased topical products for the relief of diabetic neuropathy symptoms via its earlier acquisition of Cincinatti-based 40Js.
M Pharmaceutical Inc to seek partners to distribute diabetic pain products
The pain is caused by elevated blood sugar levels

M Pharmaceutical Inc (CNSX:MQ) revealed it will immediately seek partners to market and distribute products for the relief of pain suffered by diabetics.

The firm purchased  topical products for the relief of diabetic neuropathy symptoms via its earlier acquisition of Cincinatti-based 40Js.

Gary Thompson, president and chief executive officer, said: " Diabetic neuropathy, or diabetic nerve pain, is a result of permanent damage to the nerves of the hand and feet caused by elevated blood sugar levels.

"This pain is different from pain you may have experienced from arthritis, a headache or even a sports injury."

He added it can affect the most simple of day-to-day activities for over 400 million people worldwide.

"Our product's innovative topical formulations of menthol and L-arginine paired with other key ingredients has been shown to ease this hand and leg pain. Our goal is to have distribution contracts in place and product shipping by mid summer."

The clinical-stage firm is developing innovative technologies for obesity and weight management.

View full MQ profile

M Pharmaceutical Timeline

Related Articles

Drugs
February 06 2017
The hybrid pharma services and drug development group has hit some key milestones over this year as trial results are eyed.
1-SG02055.jpg
March 22 2016
e-Therapeutics is now targeting partners to accelerate the development of its drug discovery engine and commercialise compounds.
shutterstock_139366595.jpg
January 25 2017
The company's update reveals a company in rude health
Copyright © Proactiveinvestors.com, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC